Statistics from Altmetric.com
Biological treatment, mainly with anti-tumour necrosis factor (TNF)α agents, of patients with rheumatoid arthritis, has been shown to modify their clinical course and progression, and delay or avoid its radiological progression.1,2 Disease remission in rheumatoid arthritis has been traditionally considered when there is no clinical or biochemical evidence of disease activity.3
Magnetic resonance imaging (MRI) has been shown to be more sensitive than clinical and radiological parameters in evaluating the bone erosions and the inflammatory phenomenon that …
Competing interests: None declared.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.